« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 66, Issue 3
, Pages 654-662
, 1 November 2006
Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer
References
- Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy . Cancer . 1999;86:1557–1566
- Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis . J Urol . 2002;167:1681–1686
- Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer . J Urol . 2004;172:1840–1844
- Extended pelvic lymphadenectomy for prostate cancer . J Urol . 1979;121:617–620
- Spread of prostate carcinoma to the perirectal lymph node basin . Am J Surg Pathol . 2004;28:1154–1162
- Evaluation of lymphangiography in staging carcinoma of the prostate . J Urol . 1975;113:367–370
- The sentinel lymph node concept in prostate cancer—first results of gamma probe-guided sentinel lymph node identification . Eur Urol . 1999;36:595–600
- Validity of sentinel lymph node concept for patients with prostate cancer . J Urol . 2004;171:2268–2271
- . Prostatic lymphography . J Urol . 1979;121:178–1781
- Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy . Int J Radiat Oncol Biol Phys . 2005;63:1262–1269
- Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy . Int J Radiat Oncol Biol Phys . 2005;63:1604–1612
-
Phase III trial comparing whole-pelvic versus prostate only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413
.
JCO
. 2003;21:1904–1911
- Progression free survival after whole pelvic vs. “mini-pelvic” or prostate only radiotherapy (A subset analysis of RTOG 9413, a Phase III prospective randomized trial using neoadjuvant and concurrent hormone therapy) . [Abstract] Int J Radiat Oncol Biol Phys . 2004;60:S264
- Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity modulated radiotherapy . Int J Radiat Oncol Biol Phys . 2005;63:765–771
- IMRT to escalate the dose to the prostate while treating the pelvic nodes . Strahlenther Onkol . 2005;181:431–441
- Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer? . Int J Radiat Oncol Biol Phys . 2006;64:151–160
- Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen (PSA) and Gleason score in men with clinically localized prostate cancer . Int J Radiat Oncol Biol Phys . 1994;28:33–37
- Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer . Semin Urol Oncol . 2000;18:108–114
- Low-grade toxicity after conformal radiation therapy for prostate cancer impact of bladder volume . Int J Radiat Oncol Biol Phys . 2006;64:835–841
- Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer . Int J Radiat Oncol Biol Phys . 2006;64:1151–1161
- Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.60–70.2 Gy) . Int J Radiat Oncol Biol Phys . 2003;55:688–694
- Relationships between DVH’s and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions . Radiother Oncol . 2002;64:1–12
- Finding dose-volume constraints to reduce late rectal toxicity following 3D-CRT of prostate cancer . Radiother Oncol . 2003;69:215–222
- Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer . Int J Radiat Oncol Biol Phys . 2002;54:1314–1321
- Late rectal bleeding after conformal radiotherapy for prostate cancer; volume effects and dose-volume histograms . Int J Radiat Oncol Biol Phys . 2001;49:685–698
- Impact of volume and location of irradiated rectum wall on rectal blood volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer . Int J Radiat Oncol Biol Phys . 2004;58:1072–1082
- Gastrointestinal and genitourinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial . Radiother Oncol . 2004;73:1–9
- Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume? . Cancer J . 2002;8:62–66
- Preliminary report of toxicity following 3D radiation therapy for prostate cancer of 3DOB/RTOG 9406 . Int J Radiat Oncol Biol Phys . 2000;46:391–402
- Prostate cancer radiation dose response: results of the MD Anderson phase III randomized trial . Int J Radiat Oncol Biol Phys . 2002;53:1097–1105
- Late rectal toxicity after conformal radiotherapy of prostate cancer: multivariate analysis and dose-response . Int J Radiat Oncol Biol Phys . 2000;47:103–113
- Complications for radiotherapy dose escalation in prostate cancer; preliminary results of a randomized trial . Int J Radiat Oncol Biol Phys . 2000;48:635–642
- Dose volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy . Int J Radiat Oncol Biol Phys . 2005;62:1297–1308
- Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors . Radiother Oncol . 2001;59:65–70
- Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose–volume effect . Int J Radiat Oncol Biol Phys . 2004;59:1343–1351
- Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional phase I/II dose escalation study . Int J Radiat Oncol Biol Phys . 2004;60:1351–1356
- Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer . Int J Radiat Oncol Biol Phys . 2004;60:1357–1363
- Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy . Int J Radiat Oncol Biol Phys . 1995;33:1321–1329
- Internal organ motion in prostate cancer patients treated in prone and supine treatment position . Radiother Oncol . 1999;51:237–248
- Rectal and bladder motion during conformal radiotherapy after radical prostatectomy . Radiother Oncol . 2005;74:187–195
- Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer . Radiother Oncol . 2005;74:177–185
PII: S0360-3016(06)00953-9
doi: 10.1016/j.ijrobp.2006.05.037
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 66, Issue 3
, Pages 654-662
, 1 November 2006
